Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Motus Gi Holdings Inc (MOTS)

Motus Gi Holdings Inc (MOTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,324
  • Shares Outstanding, K 5,031
  • Annual Sales, $ 320 K
  • Annual Income, $ -12,870 K
  • 60-Month Beta 1.30
  • Price/Sales 4.15
  • Price/Cash Flow N/A
  • Price/Book 0.15
Trade MOTS with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -23.56
  • Most Recent Earnings $-4.13 on 03/18/24
  • Latest Earnings Date 05/08/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -9.75
  • Growth Rate Est. (year over year) +10,346.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1621 +7.03%
on 04/15/24
0.6670 -73.99%
on 03/18/24
-0.4582 (-72.53%)
since 03/15/24
3-Month
0.1621 +7.03%
on 04/15/24
1.7000 -89.79%
on 02/21/24
-1.0065 (-85.30%)
since 01/12/24
52-Week
0.1621 +7.03%
on 04/15/24
23.3985 -99.26%
on 05/17/23
-11.9765 (-98.57%)
since 04/14/23

Most Recent Stories

More News
Motus GI Holdings, Inc. (MOTS) Reports Q1 Loss, Lags Revenue Estimates

Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 38.68% and 88.80%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

MOTS : 0.1735 (-34.06%)
OLK : 22.74 (-0.35%)
Tabula Rasa Healthcare (TRHC) Reports Q1 Loss, Tops Revenue Estimates

Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of 86.67% and 5.27%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

TRHC : 10.50 (+0.86%)
MOTS : 0.1735 (-34.06%)
Motus GI Holdings, Inc. (MOTS) Reports Q4 Loss, Lags Revenue Estimates

Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 36.80% and 72.75%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

MOTS : 0.1735 (-34.06%)
OMCL : 26.88 (-1.10%)
Motus GI Holdings, Inc. (MOTS) Reports Q3 Loss, Misses Revenue Estimates

Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 9.63% and 14.72%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

MOTS : 0.1735 (-34.06%)
COO : 92.04 (-1.58%)
Olink Holding AB publ Sponsored ADR (OLK) Reports Q3 Loss, Tops Revenue Estimates

Olink Holding AB publ Sponsored ADR (OLK) delivered earnings and revenue surprises of 91.67% and 9.15%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead...

OLK : 22.74 (-0.35%)
MOTS : 0.1735 (-34.06%)
Talkspace, Inc. (TALK) Reports Q3 Loss, Misses Revenue Estimates

Talkspace, Inc. (TALK) delivered earnings and revenue surprises of 15.38% and 2.16%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

TALK : 3.20 (-8.05%)
MOTS : 0.1735 (-34.06%)
Inspire Medical Systems (INSP) Reports Q3 Loss, Tops Revenue Estimates

Inspire (INSP) delivered earnings and revenue surprises of 20% and 14.19%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

INSP : 223.14 (-3.71%)
MOTS : 0.1735 (-34.06%)
Motus GI Holdings, Inc. (MOTS) Upgraded to Buy: What Does It Mean for the Stock?

Motus GI Holdings, Inc. (MOTS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

MOTS : 0.1735 (-34.06%)
Senseonics Holdings (SENS) Reports Q2 Loss, Tops Revenue Estimates

Senseonics (SENS) delivered earnings and revenue surprises of 25% and 12.44%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

SENS : 0.4371 (-9.13%)
MOTS : 0.1735 (-34.06%)
Tabula Rasa Healthcare (TRHC) Reports Q2 Loss, Tops Revenue Estimates

Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of -3,300% and 5.93%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

TRHC : 10.50 (+0.86%)
MOTS : 0.1735 (-34.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Motus GI Holdings, Inc. is a medical technology company. It focuses on the development and commercialization of the Pure-Vu(R) System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company also...

See More

Key Turning Points

3rd Resistance Point 0.3232
2nd Resistance Point 0.2887
1st Resistance Point 0.2311
Last Price 0.1735
1st Support Level 0.1390
2nd Support Level 0.1045
3rd Support Level 0.0469

See More

52-Week High 23.3985
Fibonacci 61.8% 14.5222
Fibonacci 50% 11.7803
Fibonacci 38.2% 9.0384
Last Price 0.1735
52-Week Low 0.1621

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar